The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Robert F. Kennedy Jr., told senators Thursday he would support the development and distribution of avian flu vaccines for people if confirmed as secretary of the Department of Health and Human ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...